Advertisement
Research ArticleINFLAMMATION AND IMMUNOPHARMACOLOGY

Resveratrol Modulates Arachidonic Acid Release, Prostaglandin Synthesis, and 3T6 Fibroblast Growth

Juan J. Moreno
Journal of Pharmacology and Experimental Therapeutics July 2000, 294 (1) 333-338;

Abstract

Previous results suggested that the cyclooxygenase-2 pathway and prostaglandins might modulate 3T6 fibroblast growth. This study shows the effect of resveratrol on the main elements of arachidonic acid (AA) cascade and 3T6 fibroblast growth. The polyphenol reduced the reactive oxygen species production stimulated by fetal calf serum or platelet-derived growth factor, as well as phospholipase A2activity translocation and the subsequent [3H]AA release and prostaglandin E2 synthesis induced by these growth factors. A Western blot analysis demonstrated that cyclooxygenase-2 induction stimulated by fetal calf serum or platelet-derived growth factor was inhibited by resveratrol. The effects of resveratrol on AA cascade were correlated with an impairment of 3T6 fibroblast proliferation and DNA synthesis. These results suggest that reactive oxygen species and AA, and/or prostaglandins such as prostaglandin E2 might be involved in the control of 3T6 fibroblast growth by resveratrol.

In normal physiological conditions, the amount of free intracellular arachidonic acid (AA) available is very small. However, the activation of phospholipases, mainly phospholipase A2(PLA2) induces the release of AA from membrane phospholipids. Then, free intracellular AA can be metabolized via cyclooxygenase (COX), lipoxygenase, or cytochrome P-450 monooxygenase pathways. Thus, this fatty acid is the precursor for the further metabolism of a large number of biologically active products, named eicosanoids (Needleman et al., 1986).

There are two isoforms of COX that catalyze the formation of prostaglandins (PGs) from AA. COX-1 is a housekeeping gene that is expressed constitutively (Smith et al., 1996), whereas COX-2 is an immediate, early response gene that is highly inducible by mitogenic and inflammatory stimuli (Kujubu et al., 1991; Hla and Neilson, 1992).

Although many studies of eicosanoids have focused on their role as intercellular messengers in physiopathological processes such as inflammation, more recent information provides strong evidence that AA and/or its metabolites play an important role in the regulation of cell proliferation. Thus, considerable evidence indicates that the COX-2 pathway is important for cell proliferation. For example, COX-2 is up-regulated in transformed cells (Kutchera et al., 1996; Subbaramaiah et al., 1996; Sheng et al., 1997). Furthermore, a null mutation for COX-2 markedly reduced the number and size of intestinal tumors in a murine model of familial adenomatous polyposis (Oshima et al., 1996).

Recently, we observed that the multiple cell contact with neighboring cells in a confluent 3T6 fibroblast monolayer inhibits PLA2 activity and, consequently, PGE2 release and 3T6 fibroblast growth (Lloret et al., 1996), a situation that can be reversed by a mechanical wound. Thus, wound injury of a confluent monolayer initiates a repair process that restores the integrity of the cell monolayer. In these previous experiments, we demonstrated that the induction of COX-2 and prostanoid synthesis, and specifically PGE2, plays an important role in induced cell proliferation and wound repair, stimulated by fetal calf serum (FCS) or platelet-derived growth factor (PDGF) in 3T6 fibroblasts cultures (Martinez et al., 1997; Moreno, 1997).

Resveratrol is a phytoalexin found in grapes and other foods that has anticancer and anti-inflammatory effects. Thus, it inhibits the development of preneoplastic lesions in carcinogen-treated mouse mammary glands, and it blocks tumorigenesis in a two-stage model of skin cancer (Jang et al., 1997). In addition, its anti-inflammatory properties were demonstrated by its suppression of carrageenan-induced paw edema, an effect attributed to suppression of PG synthesis (Jang et al., 1997). However, very little is known about the molecular basis for its biological activities. Resveratrol is endowed with antioxidant properties and inhibits the hydrogen peroxidase activity of COX-1 (Jang et al., 1997; Johnson and Madipati, 1998).

This article reports that resveratrol suppressed the production of reactive oxygen species (ROS) stimulated by FCS and PDGF in 3T6 fibroblast cultures, and that this effect was correlated with an impairment of [3H]AA release and the subsequent PGE2 synthesis, and with a decrease in 3T6 fibroblast growth. Thus, these data provide evidence that ROS and prostanoids could be involved in the antiproliferative action of resveratrol.

Materials and Methods

Reagents.

[5,6,8,9,11,12,14,15-3H]AA (180–240 Ci/mmol), phosphatidylcholine l-α-1-palmitoyl 2-arachidonyl[arachidonyl-1-14C] (60–80 Ci/mmol), and [methyl-3H]thymidine (20 Ci/mmol) were purchased from DuPont-New England Nuclear (Boston, MA). RPMI 1640 medium, FCS, penicillin G, streptomycin, and trypsin/EDTA were obtained from Life Technologies (Gaitherburg, MD). Aprotinin, leupeptin, diethyldithiocarbamic acid, phenylmethylsulfonyl fluoride, AA, PGE2, PDGF, quercetin, curcumin, and resveratrol were acquired from Sigma Chemical Co. (St. Louis, MO). Polyclonal antiserum specific against COX-2 as well as ovine COX-2 were from Cayman Chemicals (Ann Arbor, MI). Resveratrol was resuspended in dimethyl sulfoxide at 100 mM and stored at −80°C. The final concentration of dimethyl sulfoxide never exceeded 0.1%. All other reagents were of analytical grade.

Fibroblast Culture.

Murine 3T6 fibroblasts (CCL96; American Type Culture Collection, Manassas, VA) were grown and maintained as previously described (Lloret et al., 1996). Briefly, cells were grown in RPMI 1640 containing 10% FCS, penicillin (100 U/ml), and streptomycin (100 μg/ml). Cells were harvested with trypsin/EDTA and passed to tissue-culture plates with a surface area of 5 cm2/well (tissue-culture cluster 12; Costar, Cambridge, MA). Cell cultures were maintained in a temperature- and humidity-controlled incubator at 37°C with 95% air, 5% CO2. Cell viability was tested in all experimental conditions with the trypan blue exclusion test.

Determination of ROS.

Intracellular ROS levels were measured with a fluorescent dye, 2′,7′-dichlorofluorescein diacetate (DCFL-DA). For assays, medium was replaced with HBS solution (130 mM NaCl, 5 mM KCl, 2 mM CaCl2, 1 mM MgCl2, 10 mM glucose, and 10 mM HEPES, pH 7.4) containing 5 μM DCFL-DA. After 30 min of incubation at room temperature, medium was again replaced with fresh HBS solution. The fluorescent intensity in the absence or presence of stimuli was determined as described in Suzuki et al. (1998).

Cell Growth.

3T6 fibroblasts were plated at 103 cells/well in 12-well plates (Costar) and cultured for 3 days in RPMI 1640 supplemented with FCS (10%) or PDGF (10 ng/ml) in the presence of resveratrol. Finally, the cells were washed, trypsinized, and counted.

Analysis of DNA Synthesis.

DNA synthesis was measured by a [3H]thymidine incorporation assay. This involved culturing 3T6 fibroblasts in 96-well plates in RPMI 1640 with FCS (10%) or PDGF (10 ng/ml) at a density of 400 cells/well. Six hours later, cells were incubated with resveratrol and [3H]thymidine (1 μCi/well) for 24 h. [3H]Thymidine-containing media were aspirated, cells were overlaid with 1% Triton X-100, and then cells were scraped off the dishes. Finally, the radioactivity in the cell fraction was measured by scintillation counting with a Packard Tri-Carb 1500 counter.

Protein Determination.

Protein concentration was measured by the Bradford (1976) method by means of the Bio-Rad detergent-compatible protein assay, with BSA as standard.

Determination of PLA2 Activity.

PLA2 activity was measured in crude membrane and cytosolic fractions from cells. For this purpose, at the end of the experiments, the medium was replaced by cold buffer (20 mM Tris/HCl, pH 8.0; 5% saccharose). The dishes were either kept on ice for 15 min or frozen to −20°C before use. Then, fibroblasts were scraped off with a rubber policeman and briefly sonicated in the cold. To prepare crude membrane and cytosolic fractions, the homogenate was centrifuged at 100,000g for 1 h. The pellets were resuspended in buffer (20 mM Tris/HCl, pH 8.0; 5% saccharose) and PLA2 activity was determined as described inLloret et al. (1995) with the substrate proposed by Flesch and Ferber (1986), phosphatidylcholine l-α-1-palmitoyl 2-arachidonyl[arachidonyl-1-14C].

Incorporation and Release of [3H]AA.

After a period of fibroblast replication (3–4 days) and a period of FCS starvation (16 h), the medium was removed and replaced with 0.5 ml RPMI 1640 containing 0.1% fatty acid-free BSA and 0.1 μCi [3H]AA for 24 h. Cells were then washed three times in medium containing 0.5% BSA to remove unincorporated [3H]AA. After a study period, the medium was removed for analysis of radioactivity released. The amount of [3H]AA released into the medium was expressed as a percentage of cell-incorporated [3H]AA, which was determined in solubilized cells. Background release from untreated cells (9 ± 2% of 3H incorporated) was subtracted from all data.

Measurement of PGE2 Production by Fibroblasts.

An aliquot of culture supernatant medium (0.25 ml) was acidified with 1 ml of 1% formic acid. PGE2 was extracted in ethyl acetate (5 ml), and after the aqueous phase had been discarded, the organic phase was evaporated in a stream of nitrogen. The presence of PGE2 was determined with a PGE2-monoclonal enzyme immunoassay kit (Cayman Chemicals), following the manufacturer's protocol.

Western Blot Analysis of COX-2.

Fibroblast cultures were washed twice in ice-cold PBS and scraped off in PBS containing 2 mM EDTA and pelleted. Cells were sonicated in PBS containing 2 mM EDTA, 20 μg/ml phenylmethylsulfonyl fluoride, 20 μg/ml aprotinin, 20 μg/ml leupeptin, and 200 μg/ml dimethyldithiocarbamic acid. Equal amounts of protein (20 μg) were separated by a 10% SDS-polyacrylamide electrophoresis gel and immunoblot analysis for COX-2 was performed as described in Martinez et al. (1997) with a specific rabbit polyclonal antiserum anti-COX-2 (Cayman Chemicals), which did not cross-react with COX-1. Finally, antibody binding was visualized by the enhancement chemiluminescence technique (Amersham, Arlington Heights, IL).

Statistics and Data Analysis.

Results are expressed as mean ± S.E. Differences between control cultures and treated cultures were tested by using either Student's t test or one-way ANOVA followed by the least significant difference test as appropriate.

Results

PLA2 Activity Changes Induced by FCS or PDGF Are Affected by Resveratrol.

PLA2 activity can be induced to associate with natural membranes by growth factors in 3T6 fibroblasts cultures (Sanchez and Moreno, 2000). In quiescent cells only 12.8% of PLA2 activity was associated with the membrane fraction. However, our data show that FCS and PDGF caused an increase in the percentage of PLA2activity associated with the membrane fraction (33.6 and 33.3%, respectively), whereas this percentage decreased in the cytosolic fraction in the same proportion, indicating a translocation process (Figs. 1 and2). Resveratrol induced a dose-dependent inhibition on the enhancement of PLA2 activity of membrane fraction stimulated by growth factors (Figs. 1 and 2).

Figure 1
Figure 1

Distribution of PLA2 activity in 3T6 fibroblast cultures with FCS in presence of resveratrol. Preconfluent cells (10,000 cells/cm2) were maintained with FCS starvation overnight. Then, cells were incubated with FCS (10%) in the absence or presence of resveratrol for 2 h and cells were harvested and frozen for the subsequent measurement of PLA2activity in the cytosolic (▪) and membrane (■) fraction. The data represent the mean ± S.E. from three experiments performed in triplicate. *P < .05 compared with nontreated group.

Figure 2
Figure 2

Distribution of PLA2 activity in 3T6 fibroblast cultures with PDGF in the presence of resveratrol. Preconfluent cells (10,000 cells/cm2) were maintained with FCS starvation overnight. Then, cells were incubated with PDGF (10 ng/ml) in the absence or presence of resveratrol for 2 h and cells were harvested and frozen for the subsequent measurement of PLA2 activity in the cytosolic (■) and membrane (▪) fraction. The data represent the mean ± S.E. from three experiments performed in triplicate. *P < .05 compared with nontreated group.

[3H]AA Release and Subsequent PGE2Synthesis Stimulated by FCS or PDGF Are Inhibited by Resveratrol.

PLA2 activity translocation to the membrane fraction appears to be essential for AA release. Thus, this event can be correlated with [3H]AA mobilization and the subsequent metabolism through the COX pathway to synthesize prostanoids. Thus, FCS or PDGF induced [3H]AA release, whereas resveratrol at 30 μM, doses that inhibit PLA2 activity in membrane fraction, significantly reduced this release. Moreover, FCS and PDGF enhanced PGE2 synthesis, which was inhibited by resveratrol (30 μM; Table 1). Curcumin and quercetin, natural antioxidants (Cohly et al., 1998; Shutenko et al., 1999; Wang and Joseph, 1999) as is resveratrol, also had a significant effect on [3H]AA mobilization and PGE2 production (Table 1).

View this table:
Table 1

Effect of resveratrol on [3H]AA release and PGE2 synthesis induced by FCS or PDGF

Resveratrol Inhibits the Induction of COX-2 Stimulated by PDGF or H2O2.

PGs are the predominant AA metabolites synthesized by fibroblasts (Mayer et al., 1984). Two isoenzymes of COX catalyze this conversion of AA to PGs and growth factors such as FCS induce markedly the expression of COX-2 in 3T6 fibroblast cultures (Martinez et al., 1997). In this study, PDGF induced COX-2 and the treatment with resveratrol decreased PDGF-mediated induction of COX-2. Furthermore, H2O2 significantly induced the cellular COX-2 levels and resveratrol also inhibited the effect of H2O2 on COX-2 induction (Fig. 3).

Figure 3
Figure 3

Western blot analysis of COX-2 isoform in cultured murine 3T6 fibroblasts. A, lane 1, ovine COX-2 (50 ng); lane 2, cell cultured with FCS starvation overnight; lane 3, cell cultured 2 h in RPMI 1640 with PDGF (10 ng/ml); lane 4, cell cultured with PDGF in presence of resveratrol (30 μM). B, lane 1, ovine COX-2 (50 ng); lane 2, cell cultured with FCS starvation overnight; lane 3, cell cultured 2 h in RPMI 1640 with H2O2 (1 mM); lane 4, cell cultured with H2O2 (1 mM) in presence of resveratrol (30 μM). Western blot shown is representative of four experiments with similar results.

Resveratrol Reduces ROS Production Stimulated by FCS or PDGF.

ROS such as O⨪2 and H2O2 are involved in many biological processes as secondary messengers and/or as direct mediators, and they may affect cell growth (Arbault et al., 1997; Burch et al., 1997). To test this hypothesis, I monitored intracellular ROS in real time with the dye DCFL-DA, which reacts with free radical-derived oxidants to become 2′,7′-dichlorofluorescein, a highly fluorescent compound (Ohba et al., 1994). The overall intracellular levels of the oxidants in the responsive cells began to increase a few minutes after FCS or PDGF was added, reaching a maximum at 30 to 40 min (Fig. 4). Interestingly, this increase was significantly abolished by treatment with resveratrol (Fig. 4).

Figure 4
Figure 4

Changes in intracellular ROS levels of 3T6 fibroblasts after resveratrol treatment. Intracellular ROS levels were measured with DCFH-DA. Cells were untreated (open symbols) or treated (filled symbols) with resveratrol (30 μM) 30 min before assays. For assays, medium was replaced with HBS solution containing 5 μM DCFH-DA. After 40 min of incubation at room temperature, medium was replaced with fresh HBS solution. In the absence (▿) or presence of FCS 10% (■, ▪) or PDGF (10 ng/ml, ○, ●), the fluorescent intensity was monitored. Relative fluorescence intensity was calculated with untreated control cells as standard. Data are pooled from six different experiments.

Resveratrol Impaired 3T6 Fibroblast Proliferation.

To analyze the effect of resveratrol on FCS or PDGF-stimulated growth cell, 3T6 fibroblast were incubated in medium containing the growth factors with or without the polyphenol. As shown Fig.5, resveratrol significantly reduced 3T6 fibroblast growth. Similar data were obtained when I studied the effect of the polyphenol on DNA synthesis induced by FCS or PDGF. Thus, resveratrol reduced significantly the [3H]thymidine incorporation induced by the growth factors (Table 2). Same effects were obtained when curcumin or quercetin were used.

Figure 5
Figure 5

Effect of resveratrol on 3T6 fibroblast growth induced by FCS (10%, ■) or PDGF (10 ng/ml, ▪). The data represent the mean ± S.E. from three experiments performed in triplicate. *P < .05 compared with nontreated group.

View this table:
Table 2

Cell growth and DNA synthesis were affected by resveratrol

These data collectively suggest that AA and/or AA metabolites could be involved in the control of fibroblast growth by the polyphenol. PGE2 is one of the major AA metabolites produced by fibroblasts, and a correlation between PG levels in cell culture and cell growth was previously observed (Moreno, 1997). Herein, this hypothesis is supported because the inhibition of resveratrol on fibroblast proliferation and DNA synthesis was reverted when AA or PGE2 were added to the culture medium (Table 2).

Discussion

ROS are considered to be toxic to cells. However, the molecular detection and response of cells to ROS are likely to be among the earliest evolved second-messenger systems. Moreover, there is evidence that ROS are not only pathological but also, in many instances, are used as second messengers by the cell in response to growth factors (Sundaresan et al., 1995), considering that ROS are growth promoters. Thus, Shibanuma et al. (1988) reported that the treatment of 3T3 fibroblast with H2O2 plus insulin induced progression of the cell cycle from the quiescent state. Moreover, Irani et al. (1997) have reported that activation of H-Ras in fibroblasts increased ROS production, which was associated with increased cellular proliferation.

In addition, a previous report indicated that ROS could be involved in the regulation of PLA2 activity and the subsequent AA release in 3T6 fibroblasts (Martinez and Moreno, 1996). Furthermore, changes in intracellular distribution of PLA2 stimulated by growth factors may be controlled by 3T6 fibroblast growth through a mechanism dependent on PG release (Lloret et al., 1996; Moreno, 1997; Sanchez and Moreno, 1999). Thus, the impairment of 3T6 fibroblast growth induced by PLA2 inhibitors or COX inhibitors was reverted by the addition of PGE2 to the culture medium (Martinez et al., 1997; Sanchez and Moreno, 1999). On the basis of these findings, I hypothesized that active oxygen species and AA cascade metabolites could be altered in the signal transduction pathways that regulate 3T6 fibroblast growth. Furthermore, I hypothesized that these mechanisms could be interrupted by an antioxidant such as resveratrol.

In this study, I observed that PDGF or FCS increases ROS production and that resveratrol, a natural antioxidant (Frankel et al., 1993), markedly inhibits ROS produced by FCS- and PDGF-stimulated 3T6 fibroblasts. Moreover, treatment with the polyphenol reduced the FCS- or PDGF-induced translocation of PLA2 activity to the membrane fraction and the subsequent [3H]AA release and PGE2 synthesis. An 85-kDa cytosolic PLA2 is expressed in many cell types such as fibroblasts (Bunt et al., 1997) and appears to be involved in the selective AA release. Recently, several studies documented that both calcium-dependent translocation to membranes and phosphorylation are required for AA release by cystolic PLA2(Schievella et al., 1995; McNicol and Shibou, 1998). Martinez and Moreno (1996) showed that ROS are potent stimulators of signal-responsive PLA2 activity, and this study has now provided evidence that resveratrol and other polyphenols such as quercetin and curcumin could interfere in this pathway.

After AA mobilization, COX catalyzes the metabolism of AA in fibroblasts. There are two isozymes, COX-1 and COX-2, involved in PG synthesis (DeWitt, 1991). COX-1 is expressed constitutively in most cells and its activity is regulated by substrate availability, whereas COX-2 is an inducible enzyme expressed in activated 3T6 fibroblasts and involved in the control of 3T6 fibroblast growth (Martinez et al., 1997). Numerous genes and their enzyme products, including COX-2, are regulated by cellular redox status. Thus, I observed the induction of COX-2 by H2O2 at extracellular concentrations ranging from 100 μM to 1 mM H2O2 (data not shown). These concentrations are similar to the amounts of H2O2 needed to mimic the levels of intracellular H2O2 generated by PDGF treatments (Sundaresan et al., 1995). Furthermore, I observed that the induction of COX-2 by H2O2or PDGF was significantly inhibited by resveratrol, in agreement with previous results that showed that resveratrol suppressed phorbol-12-myristate-13-acetate-mediated increases in COX-2 mRNA and protein and that the polyphenol also directly inhibits the activity of COX-2 (Subbaramaiah et al., 1998). This suggests that it may be the antioxidant properties of resveratrol that modulates AA release and the subsequent AA metabolism via the COX pathway.

Interestingly, my data also show that resveratrol, curcumin, or quercetin significantly inhibit 3T6 fibroblast proliferation and DNA synthesis induced by FCS or PDGF. A decrease in cell proliferation can be attributed to either growth arrest or cell loss due to apoptosis. Growth of 3T6 fibroblast in the presence of resveratrol followed by propidium iodide staining showed that the antioxidant did not induce apoptosis in these experimental conditions (data not shown). This finding suggests that resveratrol could induce an arrest of the cell cycle as reported by Della Ragione et al. (1998) with HL-60 cells. Furthermore, the effect of resveratrol on 3T6 fibroblast growth was markedly reverted when I added AA or PGE2 to culture medium.

In summary, these data show that resveratrol inhibits 3T6 fibroblast proliferation in vitro, suggesting a direct relationship between the activity of the antioxidant to alter intracellular redox status, decrease PG synthesis, and affect cell growth. Based on these findings, I suggest that these mechanisms are involved in the effect of the polyphenol on inflammation and cancer. The location of hydroxyl functional groups at 2′, 3′, or 4′ site(s), especially at the 4′ site, as in resveratrol, curcumin, or quercetin, seems essential for anti-12-O-tetradecanoylphorbol 13-acetate induced transformatin (Lee and Lin, 1997) and could be involved in these effects on arachidonate cascade and 3T6 fibroblast proliferation. Although, I must consider that resveratrol also is able to inhibit ribonucleotide reductase (Fontecave et al., 1998) and DNA polymerase (Sun et al., 1998), and it might act as a phytoestrogen (Gehm et al., 1997).

Acknowledgment

I am very grateful to Robin Rycroft for valuable assistance in the preparation of the English manuscript.

Footnotes

  • Send reprint requests to: Dr. Juan J. Moreno, Departamento de Fisiologı́a, Facultad de Farmacia, Universidad de Barcelona, Avda. Joan XXIII s/n, E-08028 Barcelona, Spain. E-mail:moreno{at}farmacia.far.ub.es

  • ↵1 This study was supported by Spanish Ministry of Education Grants PM97-0110 and PM98-0191.

  • Abbreviations:
    AA
    arachidonic acid
    PLA2
    phospholipase A2
    COX
    cyclooxygenase
    PG
    prostaglandin
    FCS
    fetal calf serum
    PDGF
    platelet-derived growth factor
    ROS
    reactive oxygenated species
    DCFL-DA
    2′,7′-dichlorofluorescein diacetate
    • Received December 3, 1999.
    • Accepted April 10, 2000.

References

  1. ↵
    1. Arbault S,
    2. Pantano P,
    3. Sojic N,
    4. Amatore C,
    5. Best-Belpomme M,
    6. Sarasin A,
    7. Vuillaume M
    (1997) Activation of the NADPH oxidase in human fibroblast by mechanical intrusion of a single cell with an ultramicroelectrode. Carcinogenesis 18:569–574.
    OpenUrlAbstract/FREE Full Text
  2. ↵
    1. Bradford MM
    (1976) A rapid and sensitive method for the quantification of microgram quantities of protein using the principle of protein-dye binding. Anal Biochem 72:248–254.
    OpenUrlCrossRefPubMed
  3. ↵
    1. Bunt G,
    2. de Wit J,
    3. Van Den Bosch H,
    4. Verkleij AJ,
    5. Boonstra J
    (1997) Ultrastructural localization of cPLA2 in unstimulated and EGF/A23187-stimulated fibroblasts. J Cell Sci 110:2449–2459.
    OpenUrlAbstract/FREE Full Text
  4. ↵
    1. Burch HB,
    2. Lahiri S,
    3. Bahn RS,
    4. Barnes S
    (1997) Superoxide radical production stimulates retroocular fibroblast proliferation in Graves' ophthalmopathy. Exp Eye Res 65:311–316.
    OpenUrlCrossRefPubMed
  5. ↵
    1. Cohly HH,
    2. Taylor A,
    3. Angel MF,
    4. Salahudeen AK
    (1998) Effect of turmeric, turmerin and curcumin on H2O2-induced renal epithelial (LLC-PK1) cell-injury. Free Radic Biol Med 24:49–54.
    OpenUrlCrossRefPubMed
  6. ↵
    1. Della Ragione F,
    2. Cucciolla V,
    3. Borriello A,
    4. Della Pieta V,
    5. Racioppi L,
    6. Soldati G,
    7. Manna C,
    8. Galletti P,
    9. Zappia V
    (1998) Resveratrol arrest the cell division cycle at S/G2 phase transition. Biochem Biophys Res Commun 250:53–58.
    OpenUrlCrossRefPubMed
  7. ↵
    1. DeWitt DL
    (1991) Prostaglandin endoperoxide synthase: Regulation of enzyme expression. Biochim Biophys Acta 1083:121–126.
    OpenUrlPubMed
  8. ↵
    1. Flesch I,
    2. Ferber E
    (1986) Effect of cellular fatty acid composition on the phospholipase A2 activity of bone marrow-derived macrophages, and their ability to induce lucigenin-dependent chemiluminescence. Biochim Biophys Acta 889:6–14.
    OpenUrlPubMed
  9. ↵
    1. Fontecave M,
    2. Lepoivre M,
    3. Elleingand E,
    4. Gerez C,
    5. Guitter O
    (1998) Resveratrol, a remarkable inhibitor of ribonucleotide reductase. FEBS Lett 421:277–279.
    OpenUrlCrossRefPubMed
  10. ↵
    1. Frankel EN,
    2. Waterhouse AL,
    3. Kinsella JE
    (1993) Inhibition of human LDL oxidation by resveratrol. Lancet 341:1103–1104.
    OpenUrlPubMed
  11. ↵
    1. Gehm BD,
    2. Mc Andrews JM,
    3. Chieu PY,
    4. Jameson JL
    (1997) Resveratrol, a polyphenolic compound found in grapes and wines, is an agonist for the estrogen receptor. Proc Natl Acad Sci USA 94:14138–14143.
    OpenUrlAbstract/FREE Full Text
  12. ↵
    1. Hla T,
    2. Neilson K
    (1992) Human cyclooxygenase-2 cDNA. Proc Natl Acad Sci USA 89:7384–7388.
    OpenUrlAbstract/FREE Full Text
  13. ↵
    1. Irani K,
    2. Xia Y,
    3. Zweier JL,
    4. Sollott SJ,
    5. Der CJ,
    6. Fearon ER,
    7. Sundaresan M,
    8. Finkel T,
    9. Goldschmidt-Clermont PJ
    (1997) Mitogenic signaling mediated by oxidants in ras-transformed fibroblasts. Science (Wash DC) 275:1649–1652.
    OpenUrlAbstract/FREE Full Text
  14. ↵
    1. Jang M,
    2. Cai L,
    3. Udeani GO,
    4. Slowing KV,
    5. Thomas CF,
    6. Beecher CWW,
    7. Fong HHS,
    8. Farnsworth NR,
    9. Kinghorn AD,
    10. Mehta RG,
    11. Moon RC,
    12. Pezzuto JM
    (1997) Cancer chemopreventive activity of resveratrol, a natural product derived from grapes. Science (Wash DC) 275:218–220.
    OpenUrlAbstract/FREE Full Text
  15. ↵
    1. Johnson JL,
    2. Maddipati KR
    (1998) Paradoxical effects of resveratrol on the two prostaglandin H synthases. Prostaglandins 56:131–143.
  16. ↵
    1. Kujubu DA,
    2. Fletcher BS,
    3. Varnum BC,
    4. Lim RW,
    5. Herschman HR
    (1991) TIS10, a phorbol ester tumor promoter-inducible mRNA from Swiss 3T3 cells, encodes a novel prostaglandin synthase/cyclooxygenase homologue. J Biol Chem 266:12866–12872.
    OpenUrlAbstract/FREE Full Text
  17. ↵
    1. Kutchera W,
    2. Jones DA,
    3. Matsunami N,
    4. Groden J,
    5. McIntyre TM,
    6. Zimmerman GA,
    7. White RL,
    8. Prescott SM
    (1996) Prostaglandin H synthase 2 is expressed abnormally in human colon cancer: Evidence for a transcriptional effect. Proc Natl Acad Sci USA 93:4816–4820.
    OpenUrlAbstract/FREE Full Text
  18. ↵
    1. Lee SF,
    2. Lin JK
    (1997) Inhibitory effects of phytopolyphenols on TPA-induced transformation, PKC activation, and c-jun expression in mouse fibroblast cells. Nutr Cancer 28:177–183.
    OpenUrlCrossRefPubMed
  19. ↵
    1. Lloret S,
    2. Martinez J,
    3. Moreno JJ
    (1995) Influence of calcium on arachidonic acid mobilization by murine resident peritoneal macrophages. Arch Biochem Biophys 323:251–257.
    OpenUrlCrossRefPubMed
  20. ↵
    1. Lloret S,
    2. Torrent M,
    3. Moreno JJ
    (1996) Proliferation-dependent changes in arachidonic acid mobilization from phospholipids of 3T6 fibroblasts. Pfluegers Arch Eur J Physiol 432:655–662.
    OpenUrlCrossRefPubMed
  21. ↵
    1. Martinez J,
    2. Moreno JJ
    (1996) Influence of superoxide radical and hydrogen peroxide on arachidonic acid mobilization. Arch Biochem Biophys 336:191–198.
    OpenUrlCrossRefPubMed
  22. ↵
    1. Martinez J,
    2. Sanchez T,
    3. Moreno JJ
    (1997) Role of prostaglandin H synthase-2-mediated conversion of arachidonic acid in controlling 3T6 fibroblast growth. Am J Physiol 273:C1466–C1471.
    OpenUrlAbstract/FREE Full Text
  23. ↵
    1. Mayer B,
    2. Rauter Z,
    3. Zenzmnier E
    (1984) Characterization of lipoxygenase metabolites of arachidonic acid in cultured human fibroblasts. Biochim Biophys Acta 795:151–159.
    OpenUrlPubMed
  24. ↵
    1. McNicol A,
    2. Shibou TS
    (1998) Translocation and phosphorylation of cytosolic phospholipase A2 in activated platelets. Thromb Res 92:19–26.
    OpenUrlCrossRefPubMed
  25. ↵
    1. Moreno JJ
    (1997) Regulation of arachidonic acid release and prostaglandin formation by cell-cell adhesive interactions in wound repair. Pfluegers Arch Eur J Physiol 433:351–356.
    OpenUrlCrossRefPubMed
  26. ↵
    1. Needleman P,
    2. Turk J,
    3. Jakschik BA,
    4. Morrison AR,
    5. Lefkowich JB
    (1986) Arachidonic acid metabolism. Annu Rev Biochem 55:69–102.
    OpenUrlCrossRefPubMed
  27. ↵
    1. Ohba M,
    2. Shibanuma M,
    3. Kuroki T,
    4. Nose K
    (1994) Production of hydrogen peroxide by transforming growth factor-beta and the involvement in induction of egr-1 in mouse osteoblastic cells. J Cell Biol 126:1079–1088.
    OpenUrlAbstract/FREE Full Text
  28. ↵
    1. Oshima M,
    2. Dinchuk JE,
    3. Kargman SL,
    4. Oshima H,
    5. Hancock B,
    6. Kwong E,
    7. Trzaskos JM,
    8. Evans JF,
    9. Takedo MM
    (1996) Suppression of intestinal polyposis in Apc delta716 knockout mice by inhibition of cyclooxygenase 2 (COX-2). Cell 87:803–809.
    OpenUrlCrossRefPubMed
  29. ↵
    1. Sanchez T,
    2. Moreno JJ
    (1999) Ketoprofen S(+) enantiomer inhibits prostaglandin production and cell growth in 3T6 fibroblast cultures. Eur J Pharmacol 370:63–67.
    OpenUrlCrossRefPubMed
  30. ↵
    Sanchez T and Moreno JJ (2000) Role of phospholipase A2 activity and prostaglandin endoperoxide H synthase-2 expression in growth-dependent changes in prostaglandin release from fibroblasts. Cell Prolif, in press..
  31. ↵
    1. Schievella AR,
    2. Regier MK,
    3. Smith W,
    4. Lin LL
    (1995) Calcium-mediated translocation of cytosolic phospholipase A2 to the nuclear envelope and endoplasmic reticulum. J Biol Chem 2170:30749–30754.
  32. ↵
    1. Sheng GG,
    2. Shao J,
    3. Sheng H,
    4. Hooton EB,
    5. Isakson PC,
    6. Morrow JD,
    7. Coffey RJ,
    8. DuBois RN,
    9. Beauchamp RD
    (1997) A selective cyclooxygenase-2 inhibitor suppresses the growth of H-Ras-transformed rat intestinal epithelial cells. Gastroenterology 113:1883–1891.
    OpenUrlCrossRefPubMed
  33. ↵
    1. Shibanuma M,
    2. Kuroki T,
    3. Nose K
    (1988) Stimulation by hydrogen peroxide of DNA synthesis, competence family gene expression and phosphorylation of a specific protein in quiescent Balb/3T3 cells. Oncogene 3:17–21.
  34. ↵
    1. Shutenko Z,
    2. Henry Y,
    3. Pinard E,
    4. Seylaz J,
    5. Potier P,
    6. Berthet F,
    7. Girard P,
    8. Sercombe R
    (1999) Influence of the antioxidant quercetin in vivo on the level of nitric oxide determined by electron paramagnetic resonance in rat brain during global ischemia and reperfusion. Biochem Pharmacol 57:199–208.
    OpenUrlCrossRefPubMed
  35. ↵
    1. Smith WL,
    2. Garavito RM,
    3. DeWitt DL
    (1996) Prostaglandin endoperoxide H synthase (cyclooxygenases)-1 and -2. J Biol Chem 271:33157–33160.
    OpenUrlFREE Full Text
  36. ↵
    1. Subbaramaiah K,
    2. Chung WJ,
    3. Michaluart P,
    4. Telang N,
    5. Tanabe T,
    6. Inoue H,
    7. Jang M,
    8. Pezzuto JM,
    9. Dannenberg AJ
    (1998) Resveratrol inhibits cyclooxygenase-2 transcription and activity in phorbol ester-treated human mammary epithelial cells. J Biol Chem 273:21875–21882.
    OpenUrlAbstract/FREE Full Text
  37. ↵
    1. Subbaramaiah K,
    2. Telang N,
    3. Ramonetti JT,
    4. Araki R,
    5. DeVito B,
    6. Weksler BB,
    7. Dannenberg AJ
    (1996) Transcription of cyclooxygenase-2 is enhanced in transformed mammary epithelial cells. Cancer Res 56:4424–4429.
    OpenUrlAbstract/FREE Full Text
  38. ↵
    1. Sun NJ,
    2. Woo SH,
    3. Cassady JM,
    4. Shapka RM
    (1998) DNA polymerase and topoisomerase II inhibitors from Psoralea corylifolia. J Nat Prod 61:362–366.
    OpenUrlCrossRefPubMed
  39. ↵
    1. Sundaresan M,
    2. Yu ZX,
    3. Ferrans VJ,
    4. Irani K,
    5. Finkel T
    (1995) Requirement for generation of H2O2 for platelet-derived growth factor signal transduction. Science (Wash DC) 279:296–299.
    OpenUrl
  40. ↵
    1. Suzuki H,
    2. Kumagai T,
    3. Goto A,
    4. Sugiura T
    (1998) Increase in intracellular hydrogen peroxide and up-regulation of a nuclear respiratory gene evoked by impairment of mitochondrial electron transfer in human cells. Biochem Biophys Res Commun 249:542–545.
    OpenUrlCrossRefPubMed
  41. ↵
    1. Wang H,
    2. Joseph JA
    (1999) Structure-activity relationship of quercetin in antagonizing hydrogen peroxide-induced calcium dysregulation in PC12 cells. Free Radic Biol Med 27:683–694.
    OpenUrlCrossRefPubMed
Back to top

In this issue

Download PDF
Article Alerts
Email Article
Citation Tools
Research ArticleINFLAMMATION AND IMMUNOPHARMACOLOGY

Resveratrol Modulates Arachidonic Acid Release, Prostaglandin Synthesis, and 3T6 Fibroblast Growth

Juan J. Moreno
Journal of Pharmacology and Experimental Therapeutics July 1, 2000, 294 (1) 333-338;
del.icio.us logo Digg logo Reddit logo Twitter logo CiteULike logo Facebook logo Google logo Mendeley logo

Jump to section

Advertisement